Assisted Reproduction

Drug protocols for IVF compared in breast cancer patients

Published in Women's Health Weekly, November 11th, 2004

In the first study describing the use of aromatase inhibitors in breast cancer patients undergoing in vitro fertilization (IVF), Cornell University researchers compared three drug protocols for ovarian stimulation in breast cancer patients who elected to have IVF to freeze embryos before their chemotherapy.

Because standard fertility drugs increase estrogen levels, they are not considered safe in breast cancer patients. Kutluk Oktay, MD and his team used two breast cancer drugs as fertility drugs in their study.

Thirty patients were assigned to one of three protocols: tamoxifen alone, tamoxifen plus low-dose follicle stimulating hormone (FSH), or...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-11-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry